Soligenix, Inc. ( SNGX) - Key Metrics
SNGX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.12 | -$0.11 | -$0.11 |
| 2026Q1 | $0 | -$0.28 | -$0.23 | -$0.23 |
| 2025Q4 | $0 | -$0.29 | -$0.27 | -$0.27 |
| 2025Q3 | $0 | -$0.58 | -$0.68 | -$0.68 |
| 2025Q2 | $0 | -$0.82 | -$0.84 | -$0.84 |
SNGX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.83 |
| 2026Q1 | 0% | -1.05 |
| 2025Q4 | 0% | -1.16 |
| 2025Q3 | 0% | -0.50 |
| 2025Q2 | 0% | -0.40 |
SNGX
Price: $0.40
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.47 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 16498
Ebitda: -951647Market Capitalization: 8.5 million